Previous studies have shown that depletion of myofibroblasts in the tumor and reduction of fibrosis may significantly increase CTLA4 expression in ductal adenocarcinoma of the pancreas and improve the efficacy of anti-CTLA4 antibodies in mice [13]. Here, CTLA4 is linked to pancreatic ductal adenocarcinoma.